Business Wire

NICE Gives Go Ahead To NeoTract’s Groundbreaking UroLift® Prostate Implant That Can Preserve Sexual Function While Offering Urinary Symptom Relief for Millions of Men ...

PLEASANTON, Calif.--(BUSINESS WIRE)--NeoTract, Inc., today announced that the UK’s National Institute for Health and Clinical Excellence (NICE) has issued an interventional Procedure Guidance (IPG) ...
Yahoo Finance

Teleflex Incorporated Introduces the UroLift™ 2 System With Advanced Tissue Control, a Revolutionary Unified Platform Designed to Treat All Prostate Types

WAYNE, Pa., April 02, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced the upcoming full market release of the Advanced ...
Business Wire

12-Month Results from Study of NeoTract’s UroLift® System for BPH in Men with an Obstructive Median Lobe Published in Prostate Cancer and Prostatic Diseases

WAYNE, Pa.--(BUSINESS WIRE)--NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced the publication of ...

Dear Doctor: What is the Urolift procedure, and can it improve sexual function?

Most men have about a 90% improvement in prostate symptoms immediately after the procedure, which was then reduced to about 50% improvement over their baseline after five years. UroLift is very ...
Business Insider

NeoTract Designates Dr. Cameron Jirschele as UroLift® Center of Excellence

PLEASANTON, Calif., March 24, 2020 /PRNewswire-PRWeb/ -- NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today ...
Business Insider

NeoTract Designates Dr. Thomas Facelle as UroLift® Center of Excellence

PLEASANTON, Calif., Aug. 20, 2020 /PRNewswire-PRWeb/ -- NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today ...
Yahoo Finance

Teleflex (TFX) Debuts the New Unified UroLift 2 System With ATC

Teleflex TFX recently announced the upcoming full market release of the Advanced Tissue Control (“ATC”) feature on its unified UroLift 2 System — a platformdesigned for the treatment of benign ...
National Institute for Health and Care Excellence

UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia

The committee concluded that UroLift is clinically effective, with sustained relief of lower urinary tract symptoms up to 5 years after treatment. It is implanted using a minimally invasive procedure.
Nasdaq

Research Reinforcing the Effectiveness and Safety of the UroLift® System in the Real-World Setting Presented at 50th Annual ICS Meeting

WAYNE, Pa., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today announced the results of four studies that were accepted at the ICS 2020 Annual Meeting – Online reinforcing the ...
The Times Leader

Dr. Michael Rittenberg performs first urological procedures in Northeastern Pennsylvania using UroLift implant at Wilkes-Barre General Hospital

WILKES-BARRE — An innovative procedure to treat symptoms of enlarged prostates provides men with a fast and relatively comfortable alternative to traditional prostate surgeries. The new procedure, ...
The New Indian Express

Bengaluru man undergoes India’s first 4-implant UroLift surgery

BENGALURU: A 40-year-old man from Bengaluru who was suffering from an enlarged prostate gland has successfully undergone a four-implant UroLift surgery. He is the first patient in India to ...
National Institute for Health and Care Excellence

UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia

The UroLift System (Teleflex Inc.) is used to do a prostatic urethral lift, a procedure that relieves lower urinary tract symptoms. It uses implants to pull excess prostatic tissue away from the ...